Joseph Schwartz

Q: What is Joseph Schwartz's success rate?

Joseph Schwartz currently has a success rate of 93.22370462205652.

Q: What is the average return of Joseph Schwartz's calls?

Their stock ratings have generated an average return of 34.0103417684113.

Leerink Partners | Healthcare

Joseph Schwartz is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #544 out of 4745 analysts, they have issued 23 stock ratings with a success rate of 93.22% and an average return of 34.01%.

Joseph Schwartz has a well-established track record, with 23 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.22% and an average return of 34.01%, underscoring their expertise and ability to identify winning opportunities for investors.

#544

Out of 4745

Total Ratings

+93.22%

Success Rate

+34.01%

Average Return

Recent Ratings Analysis

GOSS

Buy

Jul 28, 2026

Target

$1.00

Current

$0.20

Performance

—

Joseph Schwartz rated GOSS as Outperform on Jul 28, 2026, setting a price target of 1. Shares have remained stable near 0.1994, leaving the 1 target still in play.

QNCX

Buy

Jun 24, 2026

Target

$4.00

Current

$17.85

Performance

-6.22%

On Jun 24, 2026, QNCX was given a Outperform rating by Joseph Schwartz, with a target price of 4. Despite the Buy call, shares fell from 17.85 to 17.85, challenging the optimistic stance.

QURE

Buy

Jun 18, 2026

Target

$70.00

Current

$38.21

Performance

-17.46%

QURE received a Outperform rating from Joseph Schwartz on Jun 18, 2026, aiming for 70. The rating hasn’t played out as hoped, with the stock trading 17.46% below expectations.

FULC

Hold

Jun 02, 2026

Target

$4.00

Current

$3.73

Performance

—

On Jun 02, 2026, Joseph Schwartz published a Market Perform outlook on FULC, with a target of 4. Sideways action left the Hold view intact, with no major move since 3.73.

RNA

Buy

May 15, 2026

Target

$25.00

Current

$11.57

Performance

-12.55%

Joseph Schwartz on May 15, 2026 assigned RNA a Outperform rating, with a price target of 25. The call has struggled to gain traction, with shares losing 12.55%.

ANTX

Buy

May 14, 2026

Target

$9.00

Current

$4.93

Performance

6.25%

On May 14, 2026, Joseph Schwartz reaffirmed ANTX with a Outperform rating, targeting 9. The recommendation was supported by strong follow-through as the stock rose from 4.93 to 4.93.

MSLE

Buy

Apr 06, 2026

Target

$20.00

Current

$9.46

Performance

67.35%

MSLE was rated Outperform by Joseph Schwartz on Apr 06, 2026, with a price objective of 20. A bullish response from the market helped close the gap of 10.54 to the target.

INSM

Buy

Mar 24, 2026

Target

$215.00

Current

$104.73

Performance

-24.73%

On Mar 24, 2026, Joseph Schwartz initiated coverage on INSM with a Outperform rating and target of 215. The Buy call has yet to be validated as shares remain 110.27 away from the target.

RARE

Buy

Dec 30, 2025

Target

$80.00

Current

$26.89

Performance

18.04%

Joseph Schwartz issued a Outperform recommendation for RARE on Dec 30, 2025, price target set at 80. Investors following the Buy call captured upside momentum, with shares now at 26.89.

FOLD

Hold

Dec 29, 2025

Target

$17.00

Current

$14.49

Performance

1.68%

On Dec 29, 2025, FOLD was evaluated by Joseph Schwartz, who gave a Market Perform rating and target of 17. Hold sentiment was validated by subdued trading with no breakout beyond 14.49.

DSGN

Buy

Dec 03, 2025

Target

$14.00

Current

$11.88

Performance

21.60%

Joseph Schwartz rated DSGN as Outperform on Dec 03, 2025, setting a price target of 14. The call has proven timely, with shares rising 21.60% toward the price target of 14.

APLT

Hold

Dec 03, 2025

Target

$2.00

Current

$0.10

Performance

-51.23%

On Dec 03, 2025, APLT was given a Market Perform rating by Joseph Schwartz, with a target price of 2. The rating provided protection from downside risk as the stock fell to 0.103.

AUPH

Hold

Dec 03, 2025

Target

$16.00

Current

$15.22

Performance

2.08%

AUPH received a Market Perform rating from Joseph Schwartz on Dec 03, 2025, aiming for 16. Shares remained flat at 15.22, aligning with the neutral rating.

BMRN

Hold

Dec 03, 2025

Target

$82.00

Current

$60.27

Performance

10.97%

On Dec 03, 2025, Joseph Schwartz published a Market Perform outlook on BMRN, with a target of 82. The Hold call missed some of the bullish momentum as shares advanced toward 82.

SPRB

Buy

Dec 03, 2025

Target

$160.00

Current

$41.99

Performance

-53.43%

Joseph Schwartz on Dec 03, 2025 assigned SPRB a Outperform rating, with a price target of 160. The call has struggled to gain traction, with shares losing 53.43%.

IFRX

Hold

Dec 03, 2025

Target

$5.00

Current

$1.70

Performance

66.67%

On Dec 03, 2025, Joseph Schwartz reaffirmed IFRX with a Market Perform rating, targeting 5. Market strength beyond 1.7 went further than the conservative outlook suggested.

MNPR

Buy

Nov 10, 2025

Target

$115.00

Current

$110.33

Performance

32.80%

MNPR was rated Outperform by Joseph Schwartz on Nov 10, 2025, with a price objective of 115. A bullish response from the market helped close the gap of 4.67 to the target.

CRNX

Buy

Sep 29, 2025

Target

$88.00

Current

$83.85

Performance

92.71%

On Sep 29, 2025, Joseph Schwartz initiated coverage on CRNX with a Outperform rating and target of 88. The stock’s climb of 92.71% since the call highlights the foresight in the rating.

SRPT

Hold

Sep 09, 2025

Target

$15.00

Current

$15.89

Performance

-9.92%

Joseph Schwartz issued a Market Perform recommendation for SRPT on Sep 09, 2025, price target set at 15. Market action validated the conservative Hold outlook with shares at 15.89.

KALV

Buy

Jul 07, 2025

Target

$20.00

Current

$27.00

Performance

79.28%

On Jul 07, 2025, KALV was evaluated by Joseph Schwartz, who gave a Outperform rating and target of 20. This case illustrates how a timely bullish rating can translate into tangible gains of 79.28%.

RGLS

Hold

Apr 30, 2025

Target

$7.00

Current

$8.16

Performance

2.26%

Joseph Schwartz rated RGLS as Market Perform on Apr 30, 2025, setting a price target of 7. The Hold stance appears justified, as shares hovered around 8.16 with a 2.26% move.

MAZE

Buy

Feb 25, 2025

Target

$28.00

Current

$28.69

Performance

171.43%

On Feb 25, 2025, MAZE was given a Outperform rating by Joseph Schwartz, with a target price of 28. The stock rallied 171.43% after the rating, narrowing the gap to the target of 28 and validating the bullish stance.

TVTX

Buy

Oct 11, 2024

Target

$40.00

Current

$56.68

Performance

245.40%

TVTX received a Outperform rating from Joseph Schwartz on Oct 11, 2024, aiming for 40. Momentum has favored the Buy call, with shares climbing from 56.68 to 56.68, rewarding those who trusted the recommendation.

SLDB

Buy

Jun 24, 2024

Target

$12.00

Current

$7.89

Performance

19.18%

On Jun 24, 2024, Joseph Schwartz published a Outperform outlook on SLDB, with a target of 12. Shares gained 19.18%, underscoring the accuracy of the bullish outlook toward 12.

MREO

Buy

Jun 20, 2024

Target

$8.00

Current

$0.30

Performance

-92.23%

Joseph Schwartz on Jun 20, 2024 assigned MREO a Outperform rating, with a price target of 8. The call has struggled to gain traction, with shares losing 92.23%.

Frequency Asked Questions

Who is Joseph Schwartz?

Joseph Schwartz is an analyst from Leerink Partners specializing in the Healthcare sector.

What is Joseph Schwartz's success rate?

Joseph Schwartz currently has a success rate of +93.22%.

How many ratings has Joseph Schwartz issued?

Joseph Schwartz has issued 23 stock ratings so far.

What is the average return of Joseph Schwartz's calls?

Their stock ratings have generated an average return of +34.01%.

What is Joseph Schwartz's ranking?

Joseph Schwartz is ranked #544 out of 4745 analysts.

What types of ratings does Joseph Schwartz give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Joseph Schwartz?

You can follow Joseph Schwartz by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Joseph Schwartz?

Their latest rating was a Buy on GOSS issued on 2026-07-28.